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INTRODUCTION
Epstein-Barr Virus (EBV) is a member of the human herpesvirus family. Also known as human herpesvirus 4, EBV infection is exceptionally common with over 90% of humans demonstrating a serological response to EBV exposure. The primary infection is generally mild or completely asymptomatic, though it can manifest as infectious mononucleosis in approximately 50% of infected young adults. Lymphoproliferative complications of primary EBV infection are unusual but devastating [1] and are classified within the larger family of EBV-positive lymphoproliferative disorders. [2] Primary EBV infection typically results in infectious mononucleosis or is cleared by the body with no sequelae of infection. However, in a small minority of cases, the primary exposure to EBV leads to infection of T-cells, leading to a fulminant clinical course and a generally poorer outcome. [3] EBV-positive T/NK-associated lymphoproliferative disorders of childhood are a rare but aggressive manifestation of primary EBV infection. EBV-positive hemophagocytic lymphohistiocytosis (EBV-HLH) and systemic EBV-positive T-cell lymphoma of childhood are two direct sequelae of T-cell infection by EBV, resulting in a clonal proliferation of CD8(+) cytotoxic T-cells. [4] These two entities appear to exist along the same spectrum, [5] sharing many characteristics of primary EBV infection, such as the absence of EBV IgG, but they carry very different prognoses.
In EBV-HLH, infected CD8(+) cytotoxic T-cells release a series of pro-inflammatory cytokines that leads to the activation of macrophages and histiocytes, causing immune dysregulation and a hyperinflammatory state. [6] Liver biopsies will show subtle infiltration of small T-cells in the sinusoids and portal areas, Kupffer-cell hyperplasia, and sinusoidal infiltration of these hemophagocytic histiocytes. Bone marrow aspirates from patients with EBV-HLH will show hemophagocytic histiocytes, myeloid, and erythroid hypoplasia. EBV-encoded small RNAs (EBER)-positive cells are found throughout the liver and bone marrow. EBV-HLH is the most common cause of secondary HLH, with approximately 40% of all cases of HLH due to EBV-HLH. [7] There is no overt neoplastic process in EBV-HLH, thus distinguishing it from systemic EBV-positive T-cell lymphoma of childhood.
Systemic EBV-positive T-cell lymphoma of childhood manifests as a clonal proliferation of EBV-infected cytotoxic T-cells, with a rapid progression leading to multi-organ failure, sepsis, and death, usually in the setting of a concomitant HLH syndrome. This clinical course usually presents days to weeks after an acute EBV infection. Systemic EBV-positive T-cell lymphoma of childhood is almost uniformly fatal. The presence of circulating EBV DNA is an extremely poor prognostic sign, correlating with a 100% mortality rate in all reported cases of systemic EBV-positive T-cell lymphoma of childhood. [8] Little is known about the complete systemic effects of EBV-positive T-cell lymphoma of childhood. There have been several case reports of the natural history of this disease, but the complete histological characterization of this rare disease has not been rigorously documented. In this study, we present the first complete autopsy report of a patient who developed systemic EBV-positive T-cell lymphoma of childhood.
CASE DESCRIPTION
A previously healthy 16-year-old girl with no past medical history presented with a 3-week history of vague upper respiratory tract symptoms, fatigue, and pallor. Upon her initial presentation, she was diagnosed with infectious mononucleosis following a positive mono spot test, and her symptoms subsequently resolved. She then re-presented to the emergency department following a 2-day history of abdominal pain with associated pharyngitis. Upon presentation, she was hypotensive, bicytopenic (hemoglobin concentration 90 g/L and platelet concentration 19 × 10 9 /L), hypertriglyceridemia (2.31 mmol/L), hypofibrinogenemic (0.99 g/L), hyperferritinemic (48 440.0 mcg/L), suffering from acute hepatitis (alanine aminotransferase concentration 265 units/L and aspartate aminotransferase c o n c e n t r a t i o n 1 2 4 0 u n i t s / L ) , a n d s i g n i f i c a n t coagulopathy (international normalized ratio 1.7). She was hemodynamically resuscitated with IV fluids, followed by empiric initiation of intravenous immunoglobulins and broad-spectrum antibiotics. Unfortunately, she remained hypotensive and required intensive care for vasopressor and inotropic support to maintain adequate perfusion. A bone marrow aspirate revealed a population of mature T-lymphocytes representing approximately 30% of total leukocytes [ Figure 1 ], and a bone marrow biopsy showing an interstitial infiltrate of atypical lymphocytes [ Figure 2a ], positive for CD3 [ Figure 2b ] and EBER [ Figure 2c ], consistent with HLH, and systemic EBV-positive T-cell lymphoproliferative disorder of childhood. This population was positive for CD2, CD3, CD7, CD8, HLA-DR, and alpha/beta chain, and negative for CD1a, CD4, CD5, CD34, Tdt, and gamma/delta chain. A semiquantitative PCR for serum EBV DNA also revealed EBV at a concentration of 5.68 × 10 5 copies/mL. She was started on etoposide and high dose dexamethasone. In spite aggressive supportive therapy, her clinical condition continued to decline, and she required intubation following an episode of acute respiratory distress. Multi-organ failure quickly manifested, and she developed renal failure requiring dialysis and hypoxic-ischemic encephalopathy. After several discussions about prognosis, the decision was made to withdraw life support and she passed away peacefully while surrounded by her family. The kidneys demonstrated bilateral acute tubular necrosis with hemogranular cast formation, consistent with acute kidney injury. There was extensive hemorrhage observed throughout the post-mortem examination. There were small hemorrhages within the renal parenchyma bilaterally, and an area of small hemorrhage within the right adrenal gland. There was also bilateral conjunctival hemorrhage and 100 mL of coffee-ground emesis within the stomach. There was diffuse intra-alveolar hemorrhage with associated acute and chronic inflammation extending from the alveoli into the bronchioles and bronchi bilaterally. Although this extensive hemorrhage was seen throughout all five lobes of the lungs, they were most prominent on the right side, with an associated right hemothorax (3000 mL). There was also a left pleural effusion, and her lungs had a combined postmortem weight of 1412 g.
DISCUSSION
There were several poor prognostic features in this case to explain its rapid and aggressive course, such as the marked atypia of the neoplastic CD8(+) T-cells, and the presence of circulating EBV DNA. [8] Ultimately, the terminal physiological events manifest into multi-organ failure or HLH, or a combination of both, [6, 7] and these observations were consistent with our case. The post-mortem examination revealed a monomorphic and monoclonal population of EBV-positive CD8(+) cytotoxic T-lymphocytes that had been infected with EBV. These atypical cells were found within multiple organs, with extensive infiltration of the liver, spleen, lymph nodes, and bone marrow. There was also extensive evidence of hemophagocytosis within these organs, suggestive of associated hemophagocytic lymphohistiocytosis. These findings are diagnostic of systemic This patient presented with jaundice and an elevated international normalized ratio (INR), which may be consistent with synthetic impairment due to terminal hepatic dysfunction from the extensive infiltration of these neoplastic lymphocytes into her liver. Her elevated serum transaminases, serum ferritin, ascites, and jaundice are certainly consistent with fulminant hepatitis causing a decompensated hepatopathy. However, in the context of her markedly decreased fibrinogen, her jaundice and coagulopathy strongly point toward the presence of consumptive coagulopathy. Disseminated intravascular coagulopathy (DIC) is a consumptive microfibrinous fibrinolytic state that may manifest as a terminal presentation of multi-organ failure, though it may be commonly seen in association with many hematologic malignancies. In addition, this patient demonstrated extensive areas of focal hemorrhage within the thorax, lungs, adrenals, kidneys, conjunctiva, and upper aerodigestive tract, consistent with her coagulopathic state. Although DIC has been documented in the context of advanced HLH, [9] [10] [11] these findings corroborate the observation that an element of overlap exists between the various forms of EBV-associated lymphoproliferative disorder. [6, 12, 13] Unfortunately, little else is known about this rare disease because the wealth of our knowledge comes from systematic reviews of various case reports detailing the course of this disease. [8] The consensus among observed cases is that this disease carries a dismal prognosis, with poor response to therapy, and an extremely aggressive clinical course resulting in death within days to weeks. We hope these findings provide a more comprehensive overview of several possible manifestations of EBV-associated systemic T-cell lymphoproliferative disorder of childhood.
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